Welcome to the Newsroom
30 August 2017
Prima BioMed and Monash University Receive Funding Grant for LAG-3 Research Project
SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the “Company”) announces that the Australian Research Council (ARC) has awarded Prima and research partner Monash University a A$360,000 grant under its Linkage Project scheme to help fund a research project into the role of LAG-3 in immune responses.
Article as pdf